4 deaths. there hasn't been any covid related death in the ut in the last 8 months. jan to mar 2022 as of 9 january, the total number of cases in dadra & nagar haveli and daman & diu was 10771, including 78 active cases, 10689 cures and 4 deaths. as of 15 january, the total number of cases in the ut was 10950, including 198 active cases, 10748 cures and 4 deaths. as of 22 january, the total number of cases was 11172, including 238 active cases, 10930 recoveries and 4 deaths. as of 25 january, the total number of cases was 11231, including 198 active cases, 11029 cures and 4 fatal cases. as of 5 february, the total number of cases was 11396, including 98 active cases, 11294 cures and 4 deaths. as of 11 february, the total number of cases was 11417, including 28 active cases, 11385 recoveries and 4 deaths. as of 27 february, the total number of cases was 11438, including 1 active case, 11433 recoveries and 4 deaths. as of 19 march, the total number of cases was 11441, including 1 active case, 11436 recoveries and 4 fatalities. apr to jun 2022 as of 8 april, the total number of cases in dadra & nagar haveli and daman & diu was 11441, including no active cases, 11437 cures and 4 deaths. as of 16 april, the total number of cases in dadra & nagar haveli and daman & diu was 11441, including no active cases, 11437 recoveries and 4 deaths. no single covid positive case was observed in more than a week's time in the ut. as of 2 may, the total number of cases in the ut was 11441, including no active cases, 11437 cures and 4 fatal cases. as of 12 may, the total number of cases in the ut was 11441, including no active cases, 11437 cures and 4 deaths. no single covid positive case was observed in more than a month's time in the region. as of 28 may, the total number of cases in the ut was 11441, including no active cases, 11437 cures and 4 deaths. as of 9 june, the total number of cases was 11441, including no active cases, 11437 recoveries and 4 deaths. as of 20 june, the total number of cases was 11441, including no active cases, 11437 cures and 4 deaths. no single covid positive case was observed in more than a couple of month's time in the ut. july to december 2022 as of 8 july, the total number of cases in dadra & nagar haveli and daman & diu was 11497, including 13 active cases, 11480 cures and 4 deaths. as of 16 july, the total number of cases was 11510, including 13 active cases, 11493 recoveries and 4 deaths. as of 30 august, the total number of cases was 11574, including 5 active cases, 11565 cures and 4 fatal cases. as of 4 september, the total number of cases was 11578, including 3 active cases, 11571 cures and 4 deaths. as of 17 september, the total number of cases was 11585, including 3 active cases, 11578 recoveries and 4 fatalities. as of 26 october, the total number of cases was 11588, including 1 active case, 11583 recoveries and 4 deaths. 2023 as of 22 march, the total number of cases in dadra & nagar haveli and daman & diu was 11591, including 11587 cures and 4 deaths. there wasn't any active case in the ut. covid-19 vaccines with approval for emergency or conditional usage union minister for health & family welfare, dr. harsh vardhan visiting the gtb hospital, shahdara to review the preparedness of dry run of covid-19 vaccine, in delhi on january 02, 2021. main article: covid-19 vaccine covishield on january 1, 2021, the drug controller general of india, approved the emergency or conditional use of astrazeneca's covid-19 vaccine azd1222 (marketed as covishield). covishield is developed by the university of oxford and its spin-out company, vaccitech. it's a viral vector vaccine based on replication-deficient adenovirus that causes cold in chimpanzees. it can be stored, transported and handled at normal refrigerated conditions (two-eight degrees celsius/ 36-46 degrees fahrenheit). it has a shelf-life of at least six months. on 12 january 2021 first batches of covishield vaccine was despatched from the serum institute of india. covaxin on january 2, 2021, bbv152 (marketed as covaxin), first indigenous vaccine, developed by bharat biotech in association with the indian council of medical research and national institute of virology received approval from the drug controller general of india for its emergency or conditional usage. on 14 january 2021 first batches of covaxin vaccine was despatched from the bharat biotech, albeit it was still in the third phase of testing. others on 19 may 2021, dr reddy's labs received emergency use authorisation for anti-covid drug 2-dg. on 21 february, 2022, drugs controller general of india granted approval to biological e's covid-19 vaccine corbevax, that can be used for children between 12 and 18 years of age. on 21 october 2021, india completed administering of one billion covid vaccines in the country. on 8 january 2022, india crossed 1.5 billion covid vaccines milestone in the country. on 19 february 2022, india crossed 1.75 billion covid vaccines milestone in the country.